Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk

European Journal of Cancer Prevention

Volumn 7, Issue 3, 1998, Pages 215-223

  Bartsch, H ^a,f   Malaveille, C ^a,b   Lowenfels, A B ^c   Maisonneuve, P ^d   Hautefeuille, A ^b   Boyle, P ^d   Banks, P ^e   Cavallini, G ^f   Domellof L ^g   Gullo, L ^h   Krag, E ⁱ   Lankisch, P G ^j   Pitchumoni, C S ^k   Warshaw, A L ^l  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Clinica Medica Policlinico   (Italy)

^g ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^h Dept of Med and Gastroenterology ^*  (Italy)

ⁱ Sundhedsstyrelsen   (Denmark)

^j Municipal Hospital of Lueneburg   (Germany)

^k Our Lady of Mercy Cancer Center   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Alcoholic pancreatitis; Asymptomatic Caucasian subjects; Diet; Genetic polymorphism; Glutathione; heterocyclic aromatic amines; N acetyl transferase; NAD(P)H:quinone oxidoreductase; Pancreatic cancer; S transferase M1

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; GLUTATHIONE TRANSFERASE; HETEROCYCLIC AMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; ALCOHOLIC PANCREATITIS; ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DIET; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACETYLTRANSFERASES; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; DNA; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 15644376139     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199806000-00006     Document Type: Article

References (65)

1. Anderson KE, Hammons GJ, Kadlubar FF et al (1997). Metabolic activation of aromatic amines by human pancreas. Carcinogenesis 18: 1085-92.
2. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P (1993). Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29A: 1199-207.
3. Beland FA, Kadlubar FF (1990). Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Handbook of Experimental Pharmacology. Carcinogenesis and Mutagenesis (eds Cooper CS, Grover PL); Springer-Verlag, Heidelberg. pp. 267-325.
4. Bell DA, Taylor JA, Butler MA et al (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14: 1689-92.
5. Bell DA, Stephens EA, Castraino T et al (1995a). Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55: 3537-42.
6. Bell DA, Badawi AF, Lang NP et al (1995b). Polymorphism in the N-acetylation 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226-9.
7. Board PG (1981). Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 33: 36-43.
8. Bourliere M, Barthet M, Berthezene P, Durbec JP, Sarles H (1991). Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 32: 1392-5.
9. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I (1994). Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibilty: a case-control study. Cancer Res 54: 4103-11.
10. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S, Boyle P (1991). Life-time history of smoking and exocrine carcinoma of the pancreas: A population-based case-control study in the Netherlands. Int J Cancer 49: 816-22.
11. Cadenas E (1995). Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 49: 127-40.
12. Caporaso N, Landi M T, Vineis P (1991). Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenet 1: 4-19.
13. Cole B, Ketterer B (1990). The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25: 47-70.
14. Davis CD, Schutt HAJ, Snyderwine EG (1993). Enzymatic phase II activation of N-hydroxylamines of IQ, MeIQx and PhIP in various organs of monkeys and rats. Carcinogenesis 14: 2091-6.
15. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H (1994a). Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases α and π in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 15: 219-25.
16. Eickelmann P, Schulz WA, Rohde D, Schmitz-Drager B, Sies H (1994b). Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler 375: 439-45.
17. Elexpuru-Camiruaga J, Buxton N, Kandula V et al (1995). Susceptibility to astrocytoma and meningioma: Influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 55: 4237-9.
18. Falk RT, Pickle LW, Fontham ET et al (1990). Occupation and pancreatic cancer risk in Louisiana. Am J Ind Med 18: 565-76.
19. Farrow DC, Davis S (1990). Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 45: 816-20.
20. Friesen MD, Cummings DA, Garren L et al (1996). Validation in rats of two biomarkers of response to the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): PhIP-DNA adducts and urinary PhIP. Carcinogenesis 17: 67-72.
21. Fryer AA, Zhao L, Alldersea J, Pearson WR, Strange RC (1993). Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1A, GSTM1B, GSTM1A,B and GSTM1 null polymorphisms of the glutathione S-transferase, GSTM1 locus. Biochem J 295: 313-5.
22. Ghadirian P, Simard A, Baillargeon J (1991). Tobacco, alcohol, and coffee and cancer of the pancreas. Cancer 67: 2664-70.
23. Grant DM, Blum M, Meyer VA (1992). Polymorphisms of N-acetyltransferase genes. Xenobiotica 22: 1073-81.
24. Hasegawa R, Sano M, Tawano S et al (1993). Dose dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis 14: 2553-7.
25. Hayes RB, Bi W, Rothman N et al (1993). N-Acetylation phenotype and genotype and risk of bladder cancer. Carcinogenesis 14: 675-8.
26. Hein OW, Rustan JD, Ferguson RJ, Doll MA, Gray K (1994). Metabolic activation of aromatic and heterocyclic N-hydroxylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch Toxicol 68: 129-33.
27. Hirvonen A, Nylund L, Koubu P, Husgafvel-Pursiainen K, Vainio H (1994). Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15: 813-5.
28. Howe GR, Jain M, Burch JD, Miller AB (1991). Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int J Cancer 47: 323-8.
29. Idle JR, Armstrong M, Boddy AV et al (1992). The pharmacogenetics of chemical carcinogenesis. Pharmacogenet 7: 246-58.
30. International Agency for Research on Cancer (1986). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, Tobacco Smoking. International Agency for Research on Cancer, Lyon.
31. Jaiswal AK, McBride OW, Adesnik M, Nebert DW (1988). Human dioxin-inducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localisation of gene to chromosome 16. J Biol Chem 263: 13572-8.
32. Kadlubar FF, Hammons GJ (1987). The role of cytochrome P-450 in the metabolism of chemical carcinogens. In Mammalian Cytochromes P450, Vol. II (ed Guengerich F); CRC Press, Boca Raton, pp. 81-130.
33. Kato R, Yamazoe Y (1987). Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked food and amino acid pyrolysis. Jpn J Cancer Res 78: 297-311.
34. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S-I (1993). The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87.
35. Kolesar JM, Kuhn JG, Burris III HA (1995). Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst 87: 1022-4.
36. Lang NP, Butler MA, Massengill J et al (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 3: 675-82.
37. Layton DW, Bogen KT, Knize MG et al (1995). Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 6: 39-52.
38. Lin HJ, Han CY, Bernstein DA et al (1994). Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15: 1077-81.
39. Lowenfels AB, Zwemer FL, Jhangiani S, Pitchumoni CS (1987). Pancreatitis in a native American Indian population. Pancreas 2: 694-7.
40. Manabe S, Tohyama K, Wada M, Aramaki T (1991). Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cigarette smoke condensate. Carcinogenesis 12: 1945-7.
41. Mancuso TF, El-Attar AA (1967). Cohort study of workers exposed to beta-naphthylamine and benzidine. J Occup Med 9: 277-85.
42. Minchin RF, Reeves PT, Teitel CH et al (1992). N- and O-Acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in CoS-1 cells. Biochem Biophys Res Commun 185: 839-44.
43. Monks TJ, Lau SS (1994). Glutathione conjugate mediated toxicities. In Handbook of Experimental Pharmacology: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Vol. 112 (ed Kauffman FC); Springer-Verlag, New York, pp. 459-509.
44. Norell SE, Ahlborn A, Erwals R et al (1986). Diet and pancreatic cancer: a case-control study. Am J Epidemiol 124: 894-902.
45. Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM (1989). A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health 79: 1016-9.
46. 32P-Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA damaging agent. Carcinogenesis 12: 713-7.
47. Perrett CW, Clayton RN, Pistorello M et al (1995). GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp. Carcinogenesis 7: 1643-5.
48. Pietri F, Clavel F (1991). Occupational exposure and cancer of the pancreas: a review. Br J Ind Med 48: 583-7.
49. Roots I, Drakoulis N, Brockmöller J (1992). Polymorphic enzymes and cancer risk: concepts, methodology and data review. In Pharmacogenetics of Drug Metabolism (ed Kalow W); Pergamon Press, New York, pp. 815-41.
50. Ross D, Traver RD, Siegel D et al (1996). A polymorphism in NAD(P)H: quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1cDNA to NQO activity. Br Med J 74: 995-6.
51. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH (1995). Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenet 5: 199-206.
52. Silverman DT, Dunn JA, Hoover RN et al (1994). Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 86: 1510-6.
53. Sim E, Stanley LA, Risch A, Thygesen P (1995). Xenogenetics in multifactorial disease susceptibility. Trends in Genet 11: 509-12.
54. Smith G, Stanley LA, Sim E, Strange R, Wolf CR (1995). Metabolic polymorphisms and cancer susceptibility. In Cancer Survey, Vol. 25: Genetics and Cancer: A Second Look (eds Ponder BAJ, Cavenee WK, Solomon E, Sidebottom E); Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 27.
55. 32P-Postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides formed in vivo in hepatic DNA from IQ-, MeIQ- and PhIP-treated monkeys. Carcinogenesis 14: 1389-95.
56. Spurr NK, Gough AC, Smith CAD, Wolf R (1991). Genetic analysis of cytochrome P450 system. In Methods in Enzymology. Vol. 206, Cytochrome P450 (eds Waterman MR, Johnson ER); Academic Press, New York, pp. 149-66.
57. Strange RC (1993). The glutathione S-transferase GSTM1 locus and cancer susceptibility. In Structure and Function of Glutathione S-Transferases (eds Tew K, Mannerik B, Mantle TJ, Pickett CB, Hayes JD); CRC Press, Boca Raton, FL, pp. 160-71.
58. Sugimura T (1985). Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 150: 33-41.
59. Thomas S, Brennan J, Martel G et al (1994). Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 54: 3588-93.
60. Traver RD, Horikoshi T, Danenberg KD (1992). NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 51: 797-802.
61. Vatsis KP, Weber WW (1993). Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 301: 71-6.
62. Vineis P (1992). Epidemiological models of carcinogenesis: the example of bladder cancer. Cancer Epidemiol Biomarkers Prev 1: 149-53.
63. Wakabayashi K, Nagao M, Esurni H, Sugimura T (1992). Food-derived mutagens and carcinogens. Cancer Res 52(suppl): 2092s-8s.
64. Weber WW (1995). Influence of heredity on human sensitivity to environmental chemicals. Environ Mol Mutagen 25: 102-14.
65. Weber WW, Hein DW (1985). N-Acetylation pharmacogenetics. Pharmacol Rev 37: 25-79.